BPH - Benign Prostatic Enlargement - Results from #140

Construction of early warning classification of risk in bladder spasm and its intervention plans guided by the rate adjustment card of continuous bladder irrigation after transurethral resection of the prostate (TURP): development and usability study. June 10, 2024

Suprapubic Transvesical Adenoma Resection of the Prostate (STAR-P): A Novel Technique for Surgical Treatment of Benign Prostatic Hyperplasia. June 9, 2024

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update. June 9, 2024

Association of detrusor wall thickness (DWT) with lower urinary tract symptom severity in benign prostatic hyperplasia: a cross-sectional study. June 9, 2024

Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention. June 2, 2024

Prostate Surgery for Benign Prostatic Syndrome >200 ml: Endoscopic, Robotic, or Open Approach. May 31, 2024

Thirty versus 60-Watt thulium laser enucleation of prostate: Toward the development of low-power anatomical enucleation of the prostate. May 31, 2024

Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study. May 24, 2024

Prostate volume on computed tomography correlates well with magnetic resonance imaging measurements and is reproducible across rater training levels. May 24, 2024

Five-alpha reductase inhibitors and risk of prostate cancer among men with benign prostatic hyperplasia: A historical cohort study using primary care data. May 24, 2024

Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm Study. May 24, 2024

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia using Patient-Reported Outcomes: Protocol for a Prospective Observational Study. May 20, 2024

Thulium fiber laser enucleation of the prostate: a systematic review of the current outcomes. May 19, 2024

Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia. May 19, 2024

Impact of kidney disease on perioperative outcomes of endoscopic BPH surgery: a propensity score matched analysis from the NSQIP database. May 19, 2024

Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review. May 16, 2024

Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia May 14, 2024

Transurethral Resection of the Prostate in Younger Men: Effectiveness and Long-term Outcomes. May 12, 2024

Is there a best timing for benign prostatic hyperplasia surgery? May 12, 2024

Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study. May 12, 2024

Page 8 of 142